Pediatric Pulmonology 2024 Year in Review: Rare and Diffuse Lung Disease

Pi Chun Cheng; Deborah R. Liptzin; Katiana Garagozlo; Andrew T. Barber

doi:10.1002/ppul.71096

Pediatric Pulmonology 2024 Year in Review: Rare and Diffuse Lung Disease

Pi Chun Cheng, Deborah R. Liptzin, Katiana Garagozlo, Andrew T. Barber

School of Public and Community Health Sciences

Research output: Contribution to journal › Review article › peer-review

Abstract

The field of pediatric rare and diffuse lung diseases continues to advance, with ongoing research deepening our understanding of the diagnosis and treatment of conditions such as children's interstitial and diffuse lung disease (chILD), non-cystic fibrosis (CF) bronchiectasis, and pulmonary complications of childhood cancer. Recent publications in Pediatric Pulmonology and other journals in 2024 have highlighted new insights into the pathophysiology, disease progression, and emerging diagnostic tools for these rare lung conditions, as well as innovative therapeutic approaches. This review features these important advancements within the context of current diagnostic practices and clinical care for pediatric patients with rare and diffuse lung diseases.

Original language	English
Article number	e71096
Journal	Pediatric Pulmonology
Volume	60
Issue number	4
DOIs	https://doi.org/10.1002/ppul.71096
State	Published - Apr 2025

Keywords

bronchiectasis
bronchiolitis obliterans syndrome
interstitial lung disease
primary ciliary dyskinesia
stem cell transplantation
Lung Diseases/therapy
Pediatrics
Pulmonary Medicine/trends
Humans
Rare Diseases/therapy
Lung Diseases, Interstitial/therapy
Child

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1002/ppul.71096

Cite this

@article{13a3894f95a446e18ca350a90d47db79,

title = "Pediatric Pulmonology 2024 Year in Review: Rare and Diffuse Lung Disease",

abstract = "The field of pediatric rare and diffuse lung diseases continues to advance, with ongoing research deepening our understanding of the diagnosis and treatment of conditions such as children's interstitial and diffuse lung disease (chILD), non-cystic fibrosis (CF) bronchiectasis, and pulmonary complications of childhood cancer. Recent publications in Pediatric Pulmonology and other journals in 2024 have highlighted new insights into the pathophysiology, disease progression, and emerging diagnostic tools for these rare lung conditions, as well as innovative therapeutic approaches. This review features these important advancements within the context of current diagnostic practices and clinical care for pediatric patients with rare and diffuse lung diseases.",

keywords = "bronchiectasis, bronchiolitis obliterans syndrome, interstitial lung disease, primary ciliary dyskinesia, stem cell transplantation, Lung Diseases/therapy, Pediatrics, Pulmonary Medicine/trends, Humans, Rare Diseases/therapy, Lung Diseases, Interstitial/therapy, Child",

author = "Cheng, \{Pi Chun\} and Liptzin, \{Deborah R.\} and Katiana Garagozlo and Barber, \{Andrew T.\}",

note = "{\textcopyright} 2025 The Author(s). Pediatric Pulmonology published by Wiley Periodicals LLC.",

year = "2025",

month = apr,

doi = "10.1002/ppul.71096",

language = "English",

volume = "60",

journal = "Pediatric Pulmonology",

issn = "8755-6863",

publisher = "John Wiley and Sons Inc.",

number = "4",

}

TY - JOUR

T1 - Pediatric Pulmonology 2024 Year in Review

T2 - Rare and Diffuse Lung Disease

AU - Cheng, Pi Chun

AU - Liptzin, Deborah R.

AU - Garagozlo, Katiana

AU - Barber, Andrew T.

PY - 2025/4

Y1 - 2025/4

N2 - The field of pediatric rare and diffuse lung diseases continues to advance, with ongoing research deepening our understanding of the diagnosis and treatment of conditions such as children's interstitial and diffuse lung disease (chILD), non-cystic fibrosis (CF) bronchiectasis, and pulmonary complications of childhood cancer. Recent publications in Pediatric Pulmonology and other journals in 2024 have highlighted new insights into the pathophysiology, disease progression, and emerging diagnostic tools for these rare lung conditions, as well as innovative therapeutic approaches. This review features these important advancements within the context of current diagnostic practices and clinical care for pediatric patients with rare and diffuse lung diseases.

AB - The field of pediatric rare and diffuse lung diseases continues to advance, with ongoing research deepening our understanding of the diagnosis and treatment of conditions such as children's interstitial and diffuse lung disease (chILD), non-cystic fibrosis (CF) bronchiectasis, and pulmonary complications of childhood cancer. Recent publications in Pediatric Pulmonology and other journals in 2024 have highlighted new insights into the pathophysiology, disease progression, and emerging diagnostic tools for these rare lung conditions, as well as innovative therapeutic approaches. This review features these important advancements within the context of current diagnostic practices and clinical care for pediatric patients with rare and diffuse lung diseases.

KW - bronchiectasis

KW - bronchiolitis obliterans syndrome

KW - interstitial lung disease

KW - primary ciliary dyskinesia

KW - stem cell transplantation

KW - Lung Diseases/therapy

KW - Pediatrics

KW - Pulmonary Medicine/trends

KW - Humans

KW - Rare Diseases/therapy

KW - Lung Diseases, Interstitial/therapy

KW - Child

UR - https://www.scopus.com/pages/publications/105002722385

U2 - 10.1002/ppul.71096

DO - 10.1002/ppul.71096

M3 - Review article

C2 - 40243387

AN - SCOPUS:105002722385

SN - 8755-6863

VL - 60

JO - Pediatric Pulmonology

JF - Pediatric Pulmonology

IS - 4

M1 - e71096

ER -

Pediatric Pulmonology 2024 Year in Review: Rare and Diffuse Lung Disease

Abstract

Keywords

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this